** Shares of surgical equipment maker Teleflex TFX.N fall
14% to $202.17
** Co reports Q3 rev below analysts' estimates, hurt by
weakness in its OEM unit, which designs and manufactures
instruments for other medical device makers
** TFX posts Q3 rev of $764.4 million, below analysts'
estimate of $769.6 million, according to data compiled by LSEG
** CEO Liam Kelly said co saw some "unexpected softness" in
OEM revenues
** Sales at its OEM unit came in at $82.6 million
** Co reports adj profit of $3.49 per share in the quarter
ended Sept. 30, beating estimates of $3.39 per share
** Up to last close, stock down ~6% YTD
(Reporting by Mariam Sunny in Bengaluru)
((Mariam.ESunny@thomsonreuters.com;))